Connable Office Inc’s Edwards Lifesciences EW Stock Holding History

Connable Office Inc’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-12,000	Closed	-$353K	–	185
2016 Q1	$353K	Hold	12,000	–	–	0.1%	104
2015 Q4	$316K	Hold	12,000	–	–	0.09%	116
2015 Q3	$284K	Hold	12,000	–	–	0.08%	129
2015 Q2	$285K	Hold	12,000	–	–	0.08%	141
2015 Q1	$285K	Hold	12,000	–	–	0.07%	138
2014 Q4	$255K	Hold	12,000	–	–	0.07%	146
2014 Q3	$204K	Buy	+12,000	New	+$189K	0.05%	189
2014 Q2	–	Sell	-16,200	Closed	-$200K	–	219
2014 Q1	$200K	Sell	16,200 -3,600	-18%	-$41.5K	0.05%	212
2013 Q4	$217K	Sell	19,800 -2,400	-11%	-$27.1K	0.06%	203
2013 Q3	$258K	Buy	+22,200	New	+$260K	0.07%	192

Other funds holding EW

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

VOYA Investment Management Atlanta, Georgia $116B AUM 61.47% 1-Year Est. Return

Connable Office Inc's EW Position: Q2 2016 in Review

Connable Office Inc sold out of Edwards Lifesciences (EW) in Q2 2016, closing a stake of 12,000 shares — an estimated $353K sold.

Connable Office Inc first reported a position in EW in Q3 2013 and held it in 10 quarters. The position peaked at $353K in Q1 2016. 693 funds tracked by Wall St. Rank hold EW as of Q2 2016.

Connable Office Inc reported no remaining Edwards Lifesciences position as of Q2 2016 after selling out during the quarter.
Connable Office Inc sold 12,000 Edwards Lifesciences shares in Q2 2016, an estimated $353K.
Connable Office Inc first reported a position in Edwards Lifesciences in Q3 2013 and held it in 10 quarters.
Connable Office Inc's Edwards Lifesciences position peaked at $353K in Q1 2016.
693 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2016.

Based on Connable Office Inc's 13F filing for Q2 2016, filed 4 Aug 2016.